Last $2.17 USD
Change Today +0.12 / 5.85%
Volume 1.2M
BIOL On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

biolase inc (BIOL) Snapshot

Open
$2.04
Previous Close
$2.05
Day High
$2.32
Day Low
$2.03
52 Week High
03/4/14 - $3.30
52 Week Low
05/14/14 - $1.69
Market Cap
126.1M
Average Volume 10 Days
276.7K
EPS TTM
$-0.39
Shares Outstanding
58.1M
EX-Date
08/22/05
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOLASE INC (BIOL)

Related News

No related news articles were found.

biolase inc (BIOL) Related Businessweek News

No Related Businessweek News Found

biolase inc (BIOL) Details

BIOLASE, Inc., a biomedical company, develops, manufactures, and markets lasers in dentistry and medicine in the Unites States and internationally. The company offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications. The company also markets and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners, and in-office, chair-side milling machines and three-dimensional printers, as well as provides precision intuitive diagnosis and treatment planning solutions. In addition, it offers medical systems comprising Diolase 10 Diode Laser for therapeutic applications consisting of temporary pain relief; topical heating for the purpose of temporarily relieving minor muscle and joint pain and stiffness, minor arthritis pain, muscle spasm, minor sprains and strains, and minor muscular back pain; temporarily increasing local blood circulation; and temporarily relaxing muscles. Further, the company manufactures and sells disposable products and accessories for laser systems, as well as markets flexible fibers and hand pieces. BIOLASE, Inc. has a strategic agreement with Valam, Inc. to develop, market, and sell office-based laser systems to otolaryngologists. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.

220 Employees
Last Reported Date: 03/17/14
Founded in 1984

biolase inc (BIOL) Top Compensated Officers

Vice President of Research and Development
Total Annual Compensation: $250.0K
Director of Professional Relations
Total Annual Compensation: $90.0K
Compensation as of Fiscal Year 2013.

biolase inc (BIOL) Key Developments

BIOLASE, Inc. Announces the Launch of the New WaterLase IPlus 2.0

BIOLASE, Inc. introduced dentistry’s first-ever Practice Growth Guarantee with the launch of the new, advanced WaterLase iPlus 2.0. WaterLase iPlus 2.0, the next generation of the world’s most-preferred all-tissue laser, will debut this week in the BIOLASE booth (#601) at the Chicago Dental Society’s Mid-Winter Meeting at McCormick Place West. The new laser includes important innovations and improvements resulting in satisfied patients and dental practice growth. WaterLase iPlus 2.0 also marks the debut of the SureFire YSGG Delivery System which ensures greater uptime and routine use for dentists. In addition, the laser integrates REPaiR as an app for minimally invasive treatment of periodontitis. The unique Practice Growth Guarantee is an assurance that WaterLase iPlus 2.0 will make a difference by enhancing the patient experience and generating practice growth through routine use. The WaterLase iPlus 2.0 offers key refinements and updates, including: Upgraded components to improve overall quality and performance during daily, routine use. Optimized procedure pre-sets to help dentists achieve clinical success more consistently. Improved “i” button on the main screen for easier access to help screens. The SureFire YSGG Delivery System, which results in more dependability and uptime for the dentist, includes: Redesigned optics that can more efficiently deliver precise amounts of laser energy to cut enamel, dentin and bone, in addition to the soft tissue capabilities for which the WaterLase franchise is known. A replaceable, disposable shield that protects the vital optical components in the SureFire fiber. The REPaiR laser perio app: Was based on years of clinical development by a team of periodontists and dentists from around the world including noted periodontist, educator and innovator. Includes clinical illustrations and pre-programmed settings for each step of the protocol to ensure consistent results.

BIOLASE, Inc. Announces Resignation of Frederick D. Furry as Chief Financial Officer

BIOLASE, Inc. announced that effective as of January 31, 2015, Frederick D. Furry resigned from his position as Chief Financial Officer.

BIOLASE, Inc. Introduces the EPIC X Diode Laser

BIOLASE, Inc. introduced the EPIC X diode laser, the company's premier and most complete diode laser for the whole dental team. Following up on the success of the company's EPIC 10, released in 2012, EPIC X features upgrades and improvements to ensure the best dental experience possible for dentists, their staff members and their patients. Additionally, EPIC X includes enhancements to nearly every system component to optimize treatment speed and efficiency. EPIC X offers faster procedures for three unique treatment modes -- Surgery, Whitening and Pain Relief -- all of which generate a strong return on investment, create happy patients and provide professional satisfaction. Pre-initiated tips, which are available for BIOLASE diode laser systems only, are a breakthrough because they eliminate a time-consuming task and guarantee a consistent, predictable tip condition for soft tissue surgery. The EPIC X also offers a new Reliability Assurance Plan for every EPIC X customer to ensure they are never without an EPIC X laser for more than 24 hours. This assures customers the peace of mind that they will have maximum uptime and ongoing access to the exceptional clinical and economic outcomes offered by EPIC X.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOL:US $2.17 USD +0.12

BIOL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bacterin International Holdings Inc $3.59 USD +0.3783
Cytori Therapeutics Inc $1.12 USD -0.01
Stereotaxis Inc $2.37 USD -0.06
SurModics Inc $24.05 USD +0.32
Uroplasty Inc $1.22 USD 0.00
View Industry Companies
 

Industry Analysis

BIOL

Industry Average

Valuation BIOL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.9x
Price/Book 8.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOLASE INC, please visit www.biolase.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.